169 related articles for article (PubMed ID: 6752024)
21. Effect of cycloalkyl glycosides of muramyl dipeptide on antibacterial resistance of mice and cytokine production by human mononuclear cells.
Kalyuzhin OV; Lobanov DS; Mulik EL; Kimpaeva DS; Zemlyakov AE; Kalina NG; Karaulov AV
Bull Exp Biol Med; 2009 Oct; 148(4):623-6. PubMed ID: 20396756
[TBL] [Abstract][Full Text] [Related]
22. [Antimetastatic effect of a liposome-entrapped synthetic analog of muramyl dipeptide].
Umanskiĭ VIu; Stefanov AV; Los' GV; Andronova TM; Balitskiĭ KP
Dokl Akad Nauk SSSR; 1986; 286(2):474-6. PubMed ID: 3004870
[No Abstract] [Full Text] [Related]
23. [Effect of novel derivatives of muramyl dipeptide on the immune system].
Kaliuzhin OV; Fuks BB; Bovin NV; Zemliakov AE; Chirva VIa
Biull Eksp Biol Med; 1994 May; 117(5):510-3. PubMed ID: 9296705
[No Abstract] [Full Text] [Related]
24. Stimulation of nonspecific host resistance to infection induced by muramyldipeptides.
Matsumoto K; Ogawa H; Nagase O; Kusama T; Azuma I
Microbiol Immunol; 1981; 25(10):1047-58. PubMed ID: 7031443
[TBL] [Abstract][Full Text] [Related]
25. Production of colony-stimulating factor from macrophages by muroctasin.
Yamaguchi F; Akahane K; Takashi T; Tsukada W
Arzneimittelforschung; 1988 Jul; 38(7A):983-6. PubMed ID: 3263870
[TBL] [Abstract][Full Text] [Related]
26. Persistent enhancement of cell-mediated and antibody immune responses after administration of muramyl dipeptide derivatives with antigen in metabolizable oil.
Carelli C; Audibert F; Chedid L
Infect Immun; 1981 Jul; 33(1):312-4. PubMed ID: 7263069
[TBL] [Abstract][Full Text] [Related]
27. A synthetic NOD2 agonist, muramyl dipeptide (MDP)-Lys (L18) and IFN-β synergistically induce dendritic cell maturation with augmented IL-12 production and suppress melanoma growth.
Fujimura T; Yamasaki K; Hidaka T; Ito Y; Aiba S
J Dermatol Sci; 2011 May; 62(2):107-15. PubMed ID: 21411292
[TBL] [Abstract][Full Text] [Related]
28. Effect of stearoyl-N-acetylmuramyl-L-alanyl-D-isoglutamine on host resistance to Corynebacterium kutscheri infection in cortisone-treated mice.
Ishihara C; Yamamoto K; Hamada N; Azuma I
Vaccine; 1984 Dec; 2(4):261-4. PubMed ID: 6531965
[TBL] [Abstract][Full Text] [Related]
29. Induction of tumoricidal macrophages and production of cytokines by synthetic muramyl dipeptide analogues.
Saiki I; Saito S; Fujita C; Ishida H; Iida J; Murata J; Hasegawa A; Azuma I
Vaccine; 1988 Jun; 6(3):238-44. PubMed ID: 2844032
[TBL] [Abstract][Full Text] [Related]
30. Potentiation of host defense mechanism against infection by a cytokine inducer, an acyl-MDP derivative, MDP-Lys(L18) (romurtide) in mice and humans.
Azuma I; Otani T
Med Res Rev; 1994 Jul; 14(4):401-14. PubMed ID: 8084203
[No Abstract] [Full Text] [Related]
31. A synthetic adjuvant effective in inducing antitumor immunity.
Kataoka T; Tokunaga T
Jpn J Cancer Res; 1988 Jul; 79(7):817-20. PubMed ID: 3139596
[TBL] [Abstract][Full Text] [Related]
32. Mutagenicity studies of muroctasin.
Shimada H; Hattori C; Sato T
Arzneimittelforschung; 1988 Jul; 38(7A):1031-3. PubMed ID: 3056424
[TBL] [Abstract][Full Text] [Related]
33. [Muramyl dipeptide derivatives in experimental and clinical use].
Kaliuzhin OV
Zh Mikrobiol Epidemiol Immunobiol; 1998; (1):104-8. PubMed ID: 9532704
[No Abstract] [Full Text] [Related]
34. B30-MDP, a synthetic muramyl dipeptide derivative for tumour vaccination to enhance antitumour immunity and antimetastatic effect in mice.
Yoo YC; Saiki I; Sato K; Azuma I
Vaccine; 1992; 10(11):792-7. PubMed ID: 1441733
[TBL] [Abstract][Full Text] [Related]
35. Stimulation of non-specific resistance to infections by synthetic immunoregulatory agents.
Parant M; Chedid L
Infection; 1984; 12(3):230-4. PubMed ID: 6469369
[TBL] [Abstract][Full Text] [Related]
36. Effect of muramyl dipeptide and its stearoyl derivatives on resistance to Sendai virus infection in mice.
Ishihara C; Hamada N; Yamamoto K; Iida J; Azuma I; Yamamura Y
Vaccine; 1985 Dec; 3(5):370-4. PubMed ID: 2417426
[TBL] [Abstract][Full Text] [Related]
37. Specific binding sites of muroctasin on murine macrophages.
Akasaki M; Masayasu H; Tsukada W; Takegoshi T
Arzneimittelforschung; 1988 Jul; 38(7A):978-80. PubMed ID: 3190804
[TBL] [Abstract][Full Text] [Related]
38. Immunostimulant activities of a lipophilic muramyl dipeptide derivative and of desmuramyl peptidolipid analogs.
Parant MA; Audibert FM; Chedid LA; Level MR; Lefrancier PL; Choay JP; Lederer E
Infect Immun; 1980 Mar; 27(3):826-31. PubMed ID: 7380554
[TBL] [Abstract][Full Text] [Related]
39. Enhancement of non-specific resistance to Pseudomonas pneumonia by a synthetic derivative of muramoyl dipeptide in immunosuppressed guinea pigs.
Osada Y; Ohtani T; Une T; Ogawa H; Nomoto K
J Gen Microbiol; 1982 Oct; 128(10):2361-70. PubMed ID: 7153754
[TBL] [Abstract][Full Text] [Related]
40. [Changes in purine metabolism in the macrophages of mice exposed to a new synthetic analog of muramyl dipeptide].
Umanskiĭ VIu; Tarakhovskiĭ AM; Andronova TM
Biull Eksp Biol Med; 1985 Jun; 99(6):685-7. PubMed ID: 2990603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
